Fidelity International
WST icon

Fidelity International’s West Pharmaceutical WST Stock Holding History

Fidelity International’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.38M Sell
25,439
-26,906
-51% -$6.69M 0.01% 654
2025
Q4 		$14.4M Buy
52,345
+656
+1% +$179K 0.01% 529
2025
Q3 		$13.6M Buy
51,689
+51,088
+8,500% +$12.4M 0.01% 526
2025
Q2 		$131K Sell
601
-5,339
-90% -$1.14M ﹤0.01% 915
2025
Q1 		$1.33M Hold
5,940
– – ﹤0.01% 708
2024
Q4 		$1.95M Sell
5,940
-26,415
-82% -$8.31M ﹤0.01% 685
2024
Q3 		$9.71M Sell
32,355
-26,888
-45% -$8.23M 0.01% 554
2024
Q2 		$19.5M Buy
59,243
+2,960
+5% +$1.05M 0.02% 448
2024
Q1 		$22.3M Hold
56,283
– – 0.02% 425
2023
Q4 		$19.8M Buy
+56,283
New +$19.9M 0.02% 420
2021
Q2 		– Sell
-7
Closed -$2K – 1109
2021
Q1 		$2K Hold
7
– – ﹤0.01% 877
2020
Q4 		$2K Buy
7
+1
+17% +$281 ﹤0.01% 845
2020
Q3 		$2K Sell
6
-3
-33% -$794 ﹤0.01% 845
2020
Q2 		$2K Buy
+9
New +$1.77K ﹤0.01% 824
2018
Q1 		– Sell
-94,436
Closed -$9.32M – 538
2017
Q4 		$9.32M Buy
+94,436
New +$9.26M 0.03% 359

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity International's WST Position: Q1 2026 in Review

Fidelity International reduced its West Pharmaceutical (WST) stake by 51% in Q1 2026, selling an estimated $6.69M and leaving 25,439 shares worth $6.38M. The position accounts for 0.01% of the portfolio, ranked #654.

Fidelity International first reported a position in WST in Q4 2017 and has held it in 15 quarters since. The position peaked at $22.3M in Q1 2024. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Fidelity International held 25,439 shares of West Pharmaceutical worth $6.38M as of Q1 2026.
  • Fidelity International sold 26,906 West Pharmaceutical shares in Q1 2026, an estimated $6.69M.
  • West Pharmaceutical made up 0.01% of Fidelity International's portfolio in Q1 2026, its #654 holding.
  • Fidelity International first reported a position in West Pharmaceutical in Q4 2017 and has held it in 15 quarters since.
  • Fidelity International's West Pharmaceutical position peaked at $22.3M in Q1 2024.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Fidelity International's 13F filing for Q1 2026, filed 15 May 2026.